These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 19898237)

  • 21. The Role of Donor-Specific Antibodies in Intestinal Transplantation: Experience at the University of California Los Angeles and Literature Review.
    Cheng EY; Kaneku H; Farmer DG
    Clin Transpl; 2014; ():153-9. PubMed ID: 26281140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies.
    Cuevas E; Arreola-Guerra JM; Hernández-Méndez EA; Salcedo I; Castelán N; Uribe-Uribe NO; Vilatobá M; Contreras-Saldívar AG; Sánchez-Cedillo AI; Ramírez JB; de Rungs D; Granados J; Morales-Buenrostro LE; Alberú J
    Nephrol Dial Transplant; 2016 Oct; 31(10):1738-45. PubMed ID: 27220757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients.
    Crespo E; Cravedi P; Martorell J; Luque S; Melilli E; Cruzado JM; Jarque M; Meneghini M; Manonelles A; Donadei C; Lloberas N; Gomà M; Grinyó JM; Heeger P; Bestard O
    Kidney Int; 2017 Jul; 92(1):201-213. PubMed ID: 28274484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-HLA antibodies against endothelial targets bridging allo- and autoimmunity.
    Dragun D; Catar R; Philippe A
    Kidney Int; 2016 Aug; 90(2):280-288. PubMed ID: 27188505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Donor/Recipient HLA Molecular Mismatch Scores Predict Primary Humoral and Cellular Alloimmunity in Kidney Transplantation.
    Meneghini M; Crespo E; Niemann M; Torija A; Lloberas N; Pernin V; Fontova P; Melilli E; Favà A; Montero N; Manonelles A; Cruzado JM; Palou E; Martorell J; Grinyó JM; Bestard O
    Front Immunol; 2020; 11():623276. PubMed ID: 33776988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of donor-specific HLA antibodies in transplantation, a review of the literature published in the last three years.
    Kaneku H
    Clin Transpl; 2010; ():283-306. PubMed ID: 21696047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Influenza Vaccination Inducing Antibody Mediated Rejection in Solid Organ Transplant Recipients.
    Cordero E; Bulnes-Ramos A; Aguilar-Guisado M; González Escribano F; Olivas I; Torre-Cisneros J; Gavaldá J; Aydillo T; Moreno A; Montejo M; Fariñas MC; Carratalá J; Muñoz P; Blanes M; Fortún J; Suárez-Benjumea A; López-Medrano F; Roca C; Lara R; Pérez-Romero P
    Front Immunol; 2020; 11():1917. PubMed ID: 33123119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Humoral autoimmunity and transplant vasculopathy: when allo is not enough.
    Win TS; Pettigrew GJ
    Transplantation; 2010 Jul; 90(2):113-20. PubMed ID: 20531074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-HLA Antibodies May Accelerate Immune Responses After Intestinal and Multivisceral Transplantation.
    Gerlach UA; Lachmann N; Ranucci G; Sawitzki B; Schoenemann C; Pratschke J; Dragun D; Pascher A
    Transplantation; 2017 Jan; 101(1):141-149. PubMed ID: 27495766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subclinical Antibody-Mediated Rejection.
    Arias M; Serón D; Herrero I; Rush DN; Wiebe C; Nickerson PW; Ussetti P; Rodrigo E; de Cos MA
    Transplantation; 2017 Jun; 101(6S Suppl 1):S1-S18. PubMed ID: 28538291
    [No Abstract]   [Full Text] [Related]  

  • 31. A significant role for anti-human leukocyte antigen antibodies and antibody-mediated rejection in the biopsy-for-cause population.
    Banasik M; Kościelska-Kasprzak K; Myszka M; Bartoszek D; Zabińska M; Boratyńska M; Kamińska D; Mazanowska O; Zmonarski S; Krajewska M; Hałoń A; Dawiskiba T; Nowakowska B; Klinger M
    Transplant Proc; 2014 Oct; 46(8):2613-7. PubMed ID: 25380878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Annual literature review of donor-specific HLA antibodies after organ transplantation.
    Kaneku H
    Clin Transpl; 2011; ():311-8. PubMed ID: 22755424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zbtb7a induction in alveolar macrophages is implicated in anti-HLA-mediated lung allograft rejection.
    Nayak DK; Zhou F; Xu M; Huang J; Tsuji M; Yu J; Hachem R; Gelman AE; Bremner RM; Smith MA; Mohanakumar T
    Sci Transl Med; 2017 Jul; 9(398):. PubMed ID: 28701473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a humanized mouse model to analyze antibodies specific for human leukocyte antigen (HLA).
    Yanagawa S; Tahara H; Shirouzu T; Kawai S; Tanaka Y; Ide K; Akimoto S; Ohdan H
    PLoS One; 2021; 16(2):e0236614. PubMed ID: 33544740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ABO incompatible renal transplants and decreased likelihood for developing immune responses to HLA and kidney self-antigens.
    Subramanian V; Gunasekaran M; Gaut JP; Phelan D; Vachharajani N; Santos RD; Wellen J; Shenoy S; Mohanakumar T
    Hum Immunol; 2016 Jan; 77(1):76-83. PubMed ID: 26476207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased erythrocyte C4D is associated with known alloantibody and autoantibody markers of antibody-mediated rejection in human lung transplant recipients.
    Golocheikine A; Nath DS; Basha HI; Saini D; Phelan D; Aloush A; Trulock EP; Hachem RR; Patterson GA; Ahearn JM; Mohanakumar T
    J Heart Lung Transplant; 2010 Apr; 29(4):410-6. PubMed ID: 20022265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of antibodies to human leukocyte antigen precedes development of antibodies to major histocompatibility class I-related chain A and are significantly associated with development of chronic rejection after human lung transplantation.
    Angaswamy N; Saini D; Ramachandran S; Nath DS; Phelan D; Hachem R; Trulock E; Patterson GA; Mohanakumar T
    Hum Immunol; 2010 Jun; 71(6):560-5. PubMed ID: 20211214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic antibody-mediated rejection: review of literature.
    Hassan R; Gheith O
    Iran J Kidney Dis; 2014 Mar; 8(2):93-103. PubMed ID: 24685730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplant analysis using flow cytometric techniques.
    Piazza A; Poggi E; Borrelli L; Servetti S; Monaco PI; Buonomo O; Valeri M; Torlone N; Adorno D; Casciani CU
    Transplantation; 2001 Apr; 71(8):1106-12. PubMed ID: 11374411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency of Human Leukocyte Antigens and Donor Specific Antibodies in Long-Term Living Donor Kidney Transplantation.
    Alagoz S; Seyahi N
    Transplant Proc; 2019 Sep; 51(7):2302-2307. PubMed ID: 31358448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.